研究
BioConst はホメオスタシス喪失を作業単位として始めます。最初の scout digest は、人口規模、2023 年の hallmarks 枠組み、senolytic のパイロット証拠、臨床試験の追跡を扱います。
- 初期 digest：`knowledge/research-digests/2026-05-30-bioconst-homeostasis-evidence.md`
- 現在の機序：細胞老化、プロテオスタシス、マクロオートファジー、エピジェネティック制御、栄養感知、炎症
- 証拠規則：すべての数値と事実主張には出典リンクが必要です
研究上の議論のみです。医療助言ではありません。
研究ノートBone Remodeling Shows Set-Point Drift in Plain SightThis is a research discussion, not medical advice. Bone-density concerns require qualified clinical evaluation.研究ノートBone Health Is Fracture Resistance, Not a Calcium ScoreBone health is not a reserve account with calcium as its balance. A more useful endpoint is fracture resistance: the capacity of bone, muscle, balance, and clinical context to keep ordina...研究ノートHallmarks Are a Map, Not a Cause ListThis is a research discussion, not medical advice. The purpose is classification, not diagnosis or treatment planning.研究ノートPartial Reprogramming Is a Boundary ProblemThis is a research discussion, not medical advice. BioConst does not describe any reprogramming method as ready for personal use.研究ノートProteostasis Fails as a Quality-Control StackThis is a research discussion, not medical advice. BioConst does not recommend supplements, drugs, fasting protocols, or any personal intervention from this note.研究ノートSenolytics Need a Human-Evidence LedgerThis is a research discussion, not medical advice. BioConst does not recommend dasatinib, quercetin, or any other intervention.